| Literature DB >> 31111043 |
Hani Harb1,2,3, Bilal Alashkar Alhamwe1,2,4, Daniel P Potaczek1,2,5, Annika Scheynius6,7, Nathalie Acevedo6,8, Paolo Frumento9, Catharina Johansson6, Lisa Eick1, Nikos Papadogiannakis10, Johan Alm6, Harald Renz1,2.
Abstract
Prenatal environmental exposures are considered to contribute to the development of allergic sensitization by epigenetic mechanisms. The role of histone acetylation in the placenta has not been examined yet. We hypothesized that placental histone acetylation at the promoter regions of allergy-related immune regulatory genes is associated with the development of sensitization to allergens in the child. Histones H3 and H4 acetylation at the promoter regions of 6 selected allergy-related immune regulatory genes was assessed by a chromatin immunoprecipitation assay in 173 term placentas collected in the prospective birth-cohort ALADDIN. The development of IgE sensitization to allergens in the children was followed from 6 months up to 5 years of age. We discovered significant associations of histone acetylation levels with decreased risk of allergic sensitization in 3 genes. Decreased risk of sensitization to food allergens was associated with higher H3 acetylation levels in placentas at the IFNG and SH2B3 genes, and for H4 acetylation in HDAC4. Higher HDAC4 H4 acetylation levels were also associated with a decreased risk of sensitization to aeroallergens. In conclusion, our results suggest that acetylation of histones in placenta has a potential to predict the development of sensitization to allergens in children.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31111043 PMCID: PMC6500694 DOI: 10.1155/2019/1315257
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Demographic data for the participating families and sensitization to allergens.
| Anthroposophic | Partly anthroposophic | Anthroposophic and partly anthroposophic | Non-anthroposophic | p | |
|---|---|---|---|---|---|
|
| |||||
|
| |||||
| Mother's age (years) | 30 (23-32) | 31 (28-34) | 31 (27-34) | 30 (28-33) | 0.468 |
| Mother sensitized to aeroallergensa | 5/25 (20%) | 29/105 (28%) | 34/130 (26%) | 14/43 (33%) | 0.537 |
| Father sensitized to aeroallergensa | 8/23 (35%) | 45/100 (45%) | 53/123 (43%) | 14/40 (35%) | 0.473 |
|
| |||||
|
| |||||
|
| |||||
| Parity | |||||
| First | 7/25 (28%) | 46/103 (45%) | 53/128 (41%) | 17/43 (40%) | 0.971 |
| Second | 9/25 (36%) | 40/103 (39%) | 49/128 (38%) | 18/43 (42%) | 0.814 |
| Third (fourth or fifth) | 9/25 (36%) | 17/103 (17%) | 26/128 (20%) | 8/43 (19%) | 0.982 |
|
| |||||
|
| |||||
|
| |||||
| Sex (female) | 13/25 (52%) | 52/105 (50%) | 65/130 (50%) | 28/43 (65%) | 0.122 |
| Birth weight (g) | 3550 | 3585 | 3568 | 3510 | 0.648 |
| Gestational age at birth (completed weeks) | 40 (39-41) | 40 (39-41) | 40 (39-41) | 39 (38-40) | 0.009 |
|
| |||||
|
| |||||
|
| |||||
| Food allergens at (Girls n/N; Boys n/N % p | |||||
| 6 mob (4/70 5.7; 6/63 9.5 p=0.52) | 0/16 (0%) | 4/84 (5%) | 4/100 (4%) | 6/33 (18%) | 0.022 |
| 12 mob (8/68 11.8; 10/59 16.9 p=0.45) | 0/13 (0%) | 9/77 (12%) | 9/90 (10%) | 9/37 (24%) | 0.068 |
| 2 yrsb (7/68 10.3; 13/62 21.0 p=0.14) | 2/15 (13%) | 9/79 (11%) | 11/94 (12%) | 9/36 (25%) | 0.108 |
| 5 yrsc (13/60 21.7; 8/52 15.4 p=0.47) | 1/16 (6%) | 10/69 (14%) | 11/85 (13%) | 10/27 (37%) | 0.012 |
| Aeroallergens at | |||||
| 6 mod (3/64 4.7; 0/53 0.0 p=0.25) | 0/13 (0%) | 2/72 (3%) | 2/85 (2%) | 1/32 (3%) | 0.999 |
| 12 mod (2/65 3.1; 2/56 3.6 p=1.0) | 0/12 (0%) | 1/75 (1%) | 1/87 (1%) | 3/34 (9%) | 0.120 |
| 2 yrsd (3/68 4.4; 6/60 10.0 p=0.30) | 0/15 (0%) | 4/77 (5%) | 4/92 (4%) | 5/36 (14%) | 0.130 |
| 5 yrse (11/61 18.0; 11/53 20.8 p=0.81) | 1/16 (6%) | 13/71 (18%) | 14/87 (16%) | 8/27 (30%) | 0.201 |
Categorical variables: n/N yes/total number (%). Continuous variables: median (interquartile range).
∗p for comparisons of combined anthroposophic and partly anthroposophic versus nonanthroposophic lifestyle group and for girls vs boys regarding sensitization to allergens. Categorical variables: Fisher's exact test; continuous variables: Mann-Whitney-Wilcoxon rank-sum test.
aClassified as sensitized if IgE level was ≥0.35 kUA/L measured using Phadiatop™ (Thermo Fisher Scientific) a mix of 11 aeroallergens.
bClassified as sensitized if IgE level was ≥0.35 kUA/L for at least one of the three food allergens analyzed using ImmunoCAP™ (Thermo Fisher Scientific).
cClassified as sensitized if IgE level was ≥0.35 kUA/L for at least one of the six food allergens analyzed using a food mix, fx5, followed by separate ImmunoCAP™ tests (Thermo Fisher Scientific).
dClassified as sensitized if IgE level was ≥0.35 kUA/L for at least one of the four aeroallergens analyzed using ImmunoCap™ (Thermo Fisher Scientific).
eClassified as sensitized if IgE level was ≥0.35 kUA/L for at least one of the 9 aeroallergens analyzed using Phadiatop™ followed by separate ImmunoCAP™ tests (Thermo Fisher Scientific).
Primers used for quantitative assessment of H3 or H4 histone acetylation by PCR following chromatin immunoprecipitation (ChIP).
| Gene | Forward primer | Reverse primer |
|---|---|---|
|
| ATCAGGGTTCACAGAGGA | GACCCCAAGACCCTACAC |
|
| ||
|
| ATCGTGAGGATGGATGCATTAATA | CCACTGGGAAGGTCCCTAGC |
|
| ||
|
| CTCAACACAAGCCTCCCAAG | GTGAGGGTGTGGGGTGTAG |
|
| ||
|
| AATCCCACCAGAATGGCACAGGTG | GAACAATGTGCTGCACCTCCTCTGG |
|
| ||
|
| TGTGGGAGATGCCGTGGG | TCTGACTCCCAGAAGTCTGC |
|
| ||
|
| GGAAGTGCTTGCCTTTTTCC | GGATTGCCACGGATTAACAC |
|
| ||
|
| TTGAGTGGGTGGGGCTAAAG | CCTACCAATCCCGCTAGTCC |
Figure 1The association between placental tissue histone acetylation levels at promoter regions of (a) IFNG (H3), (b) HDAC4 (H4), and (c) SH2B3 (H3) genes and the risk of sensitization to food allergens in children. For the methodology of statistical calculations, please, see Methods. Anth + Part-anth denotes a combined anthroposophic and partly anthroposophic lifestyle group and Non-anth the nonanthroposophic lifestyle. OR denotes odds ratio; 95% CI, confidence interval.
Figure 2The association between placental tissue histone H4 acetylation levels at promoter region of the HDAC4 gene and the risk of sensitization to aeroallergens in children. For the methodology of statistical calculations, please, see Methods. For abbreviations, see Figure 1. ∗Calculated with logistic regression since the number of observations in the group of boys precluded the estimations of OR and CI with the GEE model.
Figure 3Receiver operating characteristic (ROC) curves and area under the curve (AUC) obtained from different logistic regression models implemented through GEE to predict the development of sensitization to allergens. Left panel: (a) H3 acetylation (H3ac) at the IFNG promoter versus sensitization to food allergens in boys, (b) H4 acetylation (H4ac) at the HDAC4 promoter in girls versus sensitization to food allergens in girls, (c) H3 acetylation (H3ac) at the SH2B3 locus versus sensitization to food allergens in nonanthroposophic children (non-anth), and (d) H4 acetylation (H4ac) at the HDAC4 promoter versus sensitization to aeroallergens in girls. Right panel: (a-d), analogous prediction obtained when the GEE logistic model is further adjusted for the other histone acetylation variables showing significant associations with sensitization to allergens, as indicated (see also Figures 1 and 2).
(a) Histopathology of the 171 placentas available from the participating 173 mothers
| Lifestyle | Anthroposophic | Partly anthroposophic | Anthroposophic and partly anthroposophic | Non-anthroposophic | p |
|---|---|---|---|---|---|
|
| |||||
|
| |||||
| Chorioamnionitis | 9/24 (37.5%) | 44/104 (42.3%) | 53/128 (42.4%) | 20/42 (47.6%) | 0.59 |
| Vasculitis chorion plate | 1/24 (4.2%) | 15/104 (14.4%) | 16/128 (12.5%) | 7/42 (16.7%) | 0.60 |
| Vasculitis umbilical cord | 2/24 (8.3%) | 9/103 (8.6%) | 11/127 (8.5%) | 2/42 (4.8%) | 0.73 |
| Funisitis | 1/24 (4.2%) | 3/103 (2.9%) | 4/127 (3.1%) | 1/42 (2.4%) | 1.00 |
| Villitis | 4/24 (16.7%) | 20/105 (19%) | 24/129 (18.6%) | 4/42 (9.5%) | 0.23 |
∗p for comparisons of the combined anthroposophic and partly anthroposophic versus the nonanthroposophic lifestyle group by Fisher's exact test.
(b) Sensitization during childhood in relation to placenta histopathology among families with any data both from placenta and child blood sample available (N=155).
|
| At 6 months | At 12 months | At 2 years | At 5 years |
| 12/116 | 19/121 | 21/126 | 34/110 | |
|
| ||||
|
| ||||
|
| ||||
| Chorioamnionitis | 7/12 (0.37) | 10/19 (0.45) | 9/21 (0.82) | 13/34 (0.54) |
| Vasculitis chorion plate | 2/12 (0.64) | 4/19 (0.47) | 3/21 (0.73) | 7/34 (0.23) |
| Vasculitis umbilical cord | 1/12 (0.60) | 2/19 (0.73) | 2/21 (0.49) | 3/33 (0.60) |
| Funisitis | 0/12 (1.0) | 0/19 (1.0) | 0/21 (1.0) | 1/33 (0.79) |
| Villitis | 2/12 (1.0) | 2/19 (0.74) | 5/21 (0.31) | 5/34 (1.0) |
∗Fisher's exact test.